These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
610 related items for PubMed ID: 22044675
1. Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy. Fröhlich GM, Schoch B, Schmid F, Keller P, Sudano I, Lüscher TF, Noll G, Ruschitzka F, Enseleit F. Int J Cardiol; 2012 Feb 09; 154(3):328-32. PubMed ID: 22044675 [Abstract] [Full Text] [Related]
2. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, Möllmann H, Nef HN, Elsässer A, Hamm CW. J Am Coll Cardiol; 2008 Mar 25; 51(12):1188-95. PubMed ID: 18355657 [Abstract] [Full Text] [Related]
3. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction. Björklund E, Jernberg T, Johanson P, Venge P, Dellborg M, Wallentin L, Lindahl B, ASSENT-2 and ASSENT-PLUS Study Groups. Heart; 2006 Jun 25; 92(6):735-40. PubMed ID: 16251228 [Abstract] [Full Text] [Related]
4. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome. Buchner S, Debl K, Barlage S, Griese D, Fredersdorf S, Jeron A, Lubnow M, Müller T, Muders F, Holmer S, Riegger GA, Luchner A. Clin Chem Lab Med; 2010 Jun 25; 48(6):875-81. PubMed ID: 20441480 [Abstract] [Full Text] [Related]
5. Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes. Ranjith N, Pegoraro RJ, Naidoo DP, Esterhuizen TM. Cardiovasc J S Afr; 2006 Jun 25; 17(2):60-6. PubMed ID: 16733598 [Abstract] [Full Text] [Related]
6. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes. Cameron SJ, Sokoll LJ, Laterza OF, Shah S, Green GB. Clin Chim Acta; 2007 Feb 25; 376(1-2):168-73. PubMed ID: 17011538 [Abstract] [Full Text] [Related]
7. Diagnostic utility of cardiac biomarkers in discriminating Takotsubo cardiomyopathy from acute myocardial infarction. Randhawa MS, Dhillon AS, Taylor HC, Sun Z, Desai MY. J Card Fail; 2014 Jan 25; 20(1):2-8. PubMed ID: 24342256 [Abstract] [Full Text] [Related]
8. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels. Tello-Montoliu A, Marín F, Roldán V, Mainar L, López MT, Sogorb F, Vicente V, Lip GY. J Intern Med; 2007 Dec 25; 262(6):651-8. PubMed ID: 17986200 [Abstract] [Full Text] [Related]
9. Diagnostic utility of cardiac biomarkers in discriminating Takotsubo cardiomyopathy from acute myocardial infarction. Randhawa MS, Dhillon AS, Taylor HC, Sun Z, Desai MY. J Card Fail; 2014 May 25; 20(5):377.e25-31. PubMed ID: 25089311 [Abstract] [Full Text] [Related]
10. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD, Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. Circulation; 2004 Nov 16; 110(20):3206-12. PubMed ID: 15533869 [Abstract] [Full Text] [Related]
11. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis. Gravning J, Smedsrud MK, Omland T, Eek C, Skulstad H, Aaberge L, Bendz B, Kjekshus J, Mørkrid L, Edvardsen T. Am Heart J; 2013 May 16; 165(5):716-24. PubMed ID: 23622908 [Abstract] [Full Text] [Related]
12. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial. Wallentin L, Lindholm D, Siegbahn A, Wernroth L, Becker RC, Cannon CP, Cornel JH, Himmelmann A, Giannitsis E, Harrington RA, Held C, Husted S, Katus HA, Mahaffey KW, Steg PG, Storey RF, James SK, PLATO study group. Circulation; 2014 Jan 21; 129(3):293-303. PubMed ID: 24170388 [Abstract] [Full Text] [Related]
13. Assessment of anthracycline-induced cardiotoxicity with biochemical markers. Horacek JM, Pudil R, Jebavy L, Tichy M, Zak P, Maly J. Exp Oncol; 2007 Dec 21; 29(4):309-13. PubMed ID: 18199989 [Abstract] [Full Text] [Related]
14. NT-proBNP for prognostic and diagnostic evaluation in patients with acute coronary syndromes. Zdravkovic V, Mladenovic V, Colic M, Bankovic D, Lazic Z, Petrovic M, Simic I, Knezevic S, Pantovic S, Djukic A, Zdravkovic N. Kardiol Pol; 2013 Dec 21; 71(5):472-9. PubMed ID: 23788087 [Abstract] [Full Text] [Related]